⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Similasan AG and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Similasan AG
↗Jonen, Switzerland
Similasan AG is a Swiss-based pharmaceutical company specializing in the development and production of homeopathic remedies for everyday ailments. Founded in 1980, the company offers a wide range of over-the-counter (OTC) products, including eye, ear, and nasal care solutions, designed to stimulate the body's natural defenses.
The company has established a significant international presence, particularly in North America, where it operates through its subsidiary, Similasan Corporation. While Similasan is a well-known brand in the homeopathic market, its products are classified as unapproved homeopathic drugs by the FDA in the United States, and the company has faced regulatory scrutiny regarding the marketing of these products.
CLASSIFICATION
SIZE & FINANCIALS
Employees:101-250
Revenue:$40M
Founded:1980
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Homeopathic
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Similasan Corporation (USA)
Key Partnerships:Laboratoires Théa (Strategic partnership for US market entry)
COMPETITION
Position:Niche Player
Competitors:Bausch & Lomb, Alcon, Santen Pharmaceutical, Boiron, Rohto Pharmaceutical
LEADERSHIP
Key Executives:
Armin Spaeni - Founder
Dan Quail - President, North America
Scientific Founders:Armin Spaeni
LINKS
Website:similasan.swiss
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Similasan AG. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.